{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:35:01Z","timestamp":1767843301558,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.10.064","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T08:40:08Z","timestamp":1288946408000},"page":"501-511","source":"Crossref","is-referenced-by-count":48,"title":["VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone"],"prefix":"10.1016","volume":"29","author":[{"given":"Leonard","family":"Moise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Mark","family":"Buller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Schriewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon E.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne S.","family":"De Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2010.10.064_bib0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/156652405774962326","article-title":"Countermeasures to the bioterrorist threat of smallpox","volume":"5","author":"Jahrling","year":"2005","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.vaccine.2010.10.064_bib0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199808203390811","article-title":"Poxvirus dilemmas\u2014monkeypox, smallpox, and biologic terrorism","volume":"339","author":"Bremen","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.10.064_bib0015","unstructured":"Testimony of Stephen M. Ostroff. March 8, 2000; U.S. House of Representatives Committee on Commerce. National Security, Veterans Affairs, and International Relations. Available at: URL: www.bt.cdc.gov\/press\/ostroff_03082000.asp."},{"key":"10.1016\/j.vaccine.2010.10.064_bib0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.vaccine.2010.10.064_bib0030","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus","volume":"105","author":"Earl","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.064_bib0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coi.2009.04.004","article-title":"The immunology of smallpox vaccines","volume":"21","author":"Kennedy","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2010.10.064_bib0040","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel","volume":"289","author":"Halsell","year":"2003","journal-title":"JAMA"},{"issue":"32","key":"10.1016\/j.vaccine.2010.10.064_bib0045","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1016\/j.vaccine.2008.05.044","article-title":"US military service members vaccinated against smallpox in 2003 and 2004 experience a slightly higher risk of hospitalization postvaccination","volume":"26","author":"Jacobson","year":"2008","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2010.10.064_bib0050","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.vaccine.2008.11.079","article-title":"Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults","volume":"27","author":"Frey","year":"2009","journal-title":"Vaccine"},{"issue":"51","key":"10.1016\/j.vaccine.2010.10.064_bib0055","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","article-title":"Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge","volume":"25","author":"Frey","year":"2007","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2010.10.064_bib0060","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1016\/j.vaccine.2009.06.018","article-title":"In silico-accelerated identification of conserved and immunogenic variola\/vaccinia T-cell epitopes","volume":"27","author":"Moise","year":"2009","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2010.10.064_bib0065","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.vaccine.2005.01.097","article-title":"HIV vaccine development by computer assisted design: the GAIA vaccine","volume":"23","author":"De Groot","year":"2005","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2010.10.064_bib0070","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1016\/S0264-410X(01)00233-X","article-title":"Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines","volume":"19","author":"Livingston","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.064_bib0075","unstructured":"FDA Center for Biologics Evaluation and Research (CBER). Points to Consider on Plasmid DNA Vaccines for Preventive Infectious Diseases Indications (Docket no. 96N-0400)."},{"issue":"6","key":"10.1016\/j.vaccine.2010.10.064_bib0080","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.4049\/jimmunol.167.6.3324","article-title":"Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides","volume":"167","author":"Gursel","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.064_bib0085","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1084\/jem.184.3.1167","article-title":"HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene","volume":"184","author":"Kong","year":"1996","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2010.10.064_bib0090","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.4049\/jimmunol.175.5.3287","article-title":"TNF-alpha-dependent and -independent maturation of dendritic cells and recruited CD11(int)CD11b(+) cells during oral Salmonella infection","volume":"175","author":"Sundquist","year":"2005","journal-title":"J Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2010.10.064_bib0095","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.vaccine.2005.03.029","article-title":"Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge","volume":"24","author":"Empig","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.064_bib0100","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","article-title":"A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes","volume":"168","author":"Livingston","year":"2002","journal-title":"J Immunol"},{"issue":"47","key":"10.1016\/j.vaccine.2010.10.064_bib0105","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1016\/j.vaccine.2008.07.103","article-title":"A heterologous DNA prime\/protein boost immunization strategy for rhesus cytomegalovirus","volume":"26","author":"Abel","year":"2008","journal-title":"Vaccine"},{"issue":"7225","key":"10.1016\/j.vaccine.2010.10.064_bib0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature07469","article-title":"Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys","volume":"457","author":"Liu","year":"2009","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.064_bib0115","first-page":"259","article-title":"Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells","volume":"13","author":"Tanguay","year":"1994","journal-title":"Lymphokine Cytokine Res"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.064_bib0120","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1128\/JVI.69.2.1288-1291.1995","article-title":"Induction of cytokines in mice with parainfluenza pneumonia","volume":"69","author":"Mo","year":"1995","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.10.064_bib0125","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.4049\/jimmunol.178.10.6374","article-title":"Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus","volume":"178","author":"Jing","year":"2007","journal-title":"J Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2010.10.064_bib0130","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1128\/JVI.00453-08","article-title":"An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling","volume":"82","author":"Jing","year":"2008","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.10.064_bib0135","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1371\/journal.ppat.0030144","article-title":"Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection","volume":"3","author":"Calvo-Calle","year":"2007","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.vaccine.2010.10.064_bib0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"6081","key":"10.1016\/j.vaccine.2010.10.064_bib0145","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/322747a0","article-title":"Continuous and discontinuous protein antigenic determinants","volume":"322","author":"Barlow","year":"1986","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vaccine.2010.10.064_bib0150","doi-asserted-by":"crossref","first-page":"e1000231","DOI":"10.1371\/journal.pcbi.1000231","article-title":"Structural and thermodynamic approach to peptide immunogenicity","volume":"4","author":"Camacho","year":"2008","journal-title":"PLoS Comput Biol"},{"issue":"January","key":"10.1016\/j.vaccine.2010.10.064_bib0155","article-title":"Antiviral protection following immunization correlates with humoral but not cell-mediated immunity","author":"Panchanathan","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2010.10.064_bib0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4899-1382-1_22","article-title":"Hypothesis: how licensed vaccines confer protective immunity","volume":"397","author":"Robbins","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2010.10.064_bib0165","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/eji.200838815","article-title":"Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model","volume":"39","author":"Moutaftsi","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2010.10.064_bib0170","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","article-title":"Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses","volume":"78","author":"Snyder","year":"2004","journal-title":"J Virol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.10.064_bib0175","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1413","article-title":"Helping the CD8(+) T-cell response","volume":"4","author":"Bevan","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2010.10.064_bib0180","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.10.064_bib0185","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against vaccinia virus infection of mice","volume":"172","author":"Xu","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.10.064_bib0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: an emerging zoonotic disease","volume":"2","author":"Parker","year":"2007","journal-title":"Future Microbiol"},{"issue":"18","key":"10.1016\/j.vaccine.2010.10.064_bib0195","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1089\/088922202320935438","article-title":"Phase I trial of a therapeutic HIV type 1 vaccine, Vacc-4x, in HIV type 1-infected individuals with or without antiretroviral therapy","volume":"18","author":"Asj\u00f6","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"14","key":"10.1016\/j.vaccine.2010.10.064_bib0200","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1097\/00002030-200409240-00003","article-title":"HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)","volume":"18","author":"Kran","year":"2004","journal-title":"AIDS"},{"issue":"14","key":"10.1016\/j.vaccine.2010.10.064_bib0205","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2174\/092986706777441922","article-title":"Design of peptide-based vaccines for cancer","volume":"13","author":"Pietersz","year":"2006","journal-title":"Curr Med Chem"},{"issue":"16","key":"10.1016\/j.vaccine.2010.10.064_bib0210","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.vaccine.2007.01.039","article-title":"Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine","volume":"25","author":"McMurry","year":"2007","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2010.10.064_bib0215","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1016\/j.vaccine.2009.06.101","article-title":"Epitope-based vaccination against Pneumonic Tularemia","volume":"27","author":"Gregory","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10015653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10015653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T14:58:00Z","timestamp":1592060280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10015653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X10015653"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}